All Episodes

Harold Varmus, co-recipient of the 1989 Nobel Prize for Physiology or Medicine, has served as the President of Memorial Sloan Kettering Cancer Center since January 2000. Watch Dr. Varmus introduces the seminar’s senior investigators.

Watch cancer biologist, Johanna Joyce, as she explains how normal cells in the tumor microenvironment can have a positive and a negative influence on cancer progression, depending on the stage of tumor development.

Harold Varmus, co-recipient of the 1989 Nobel Prize for Physiology or Medicine, has served as the President of Memorial Sloan Kettering Cancer Center since January 2000. Dr. Varmus introduces the seminar’s three senior investigators.

Joan Massagué is an internationally recognized leader in the fields of cancer metastasis (the spread of cancers in the body) and growth factors that regulate cell behavior. In this lecture, Dr. Massagué explains how scientists and clinicians in Memorial Sloan Kettering laboratories are developing new ways to fight metastasis.

A physician-scientist and Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, Charles Sawyers studies how signaling pathway abnormalities in cancer cells can be exploited as targets for new cancer drugs. In this lecture, Dr. Sawyers discusses how recent success in targeted therapy is changing the way we hope to treat other cancers.

Here at Memorial Sloan Kettering, David Scheinberg is pursuing the development of novel targeted cancer therapies, including antibodies and vaccines. In this lecture, Dr. Scheinberg explains how new therapies are being discovered and developed into effective cancer treatments.

Memorial Sloan Kettering Cancer Center feted three gifted young investigators for their insightful contributions to cancer research in a public symposium held at the Center on December 1, 2011. The 2011 recipients of the Paul Marks Prize are Scott A. Armstrong, Kornelia Polyak, and Victor E. Velculescu.